Bristol Myers Squibb's Cobenfy as an adjunctive treatment did not reach the threshold for a statistically significant difference compared to a placebo with an atypical antipsychotic in adults with ...

Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) will be announcing earnings results tomorrow morning. Here’s what investors should know. Bristol-Myers Squibb beat analysts’ revenue ...

Bristol Myers Squibb on Thursday beat first-quarter estimates and hiked its revenue and profit guidance for the year, as the drugmaker cuts costs. The company now expects 2025 revenue to come in ...

Bristol Myers posts higher-than-expected quarterly revenue on cancer drug sales Bristol Myers Squibb reported higher-than-expected first-quarter revenue on Thursday and raised its full-year ...

7 analysts have shared their evaluations of Bristol-Myers Squibb (NYSE:BMY) during the recent three months, expressing a mix of bullish and bearish perspectives. The following table provides a ...

PRINCETON, N.J. (AP) — PRINCETON, N.J. (AP) — Bristol Myers Squibb Co. (BMY) on Thursday reported first-quarter net income of $2.46 billion, after reporting a loss in the same period a year ...